Header Logo

Connection

Naoko Takebe to CTLA-4 Antigen

Back to Details
This is a "connection" page, showing publications Naoko Takebe has written about CTLA-4 Antigen.
Naoko Takebe
Connection Strength
0.139
CTLA-4 Antigen
  1. Combined KIT and CTLA-4 Blockade in Patients with Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib plus Ipilimumab. Clin Cancer Res. 2017 Jun 15; 23(12):2972-2980.
    View in: PubMed
    Score: 0.139
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.